In last trading session, PAVmed Inc (NASDAQ:PAVM) saw 0.22 million shares changing hands with its beta currently measuring 0.72. Company’s recent per share price level of $0.62 trading at -$0.02 or -3.05% at ring of the bell on the day assigns it a market valuation of $6.85M. That closing price of PAVM’s stock is at a discount of -472.58% from its 52-week high price of $3.55 and is indicating a premium of 8.06% from its 52-week low price of $0.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.47 million shares which gives us an average trading volume of 135.64K if we extend that period to 3-months.

PAVmed Inc (NASDAQ:PAVM) trade information

Upright in the red during last session for losing -3.05%, in the last five days PAVM remained trading in the red while hitting it’s week-highest on Friday, 01/03/25 when the stock touched $0.62 price level, adding 18.42% to its value on the day. PAVmed Inc’s shares saw a change of -1.29% in year-to-date performance and have moved -1.29% in past 5-day. PAVmed Inc (NASDAQ:PAVM) showed a performance of -36.14% in past 30-days. Number of shares sold short was 0.28 million shares which calculate 9.07 days to cover the short interests.

PAVmed Inc (PAVM) estimates and forecasts

Statistics highlight that PAVmed Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -23.52% of value to its shares in past 6 months, showing an annual growth rate of 53.46% while that of industry is 14.80. Apart from that, the company came raising its revenue forecast for fiscal year 2025.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 6.21% during past 5 years.

PAVmed Inc (NASDAQ:PAVM)’s Major holders

Insiders are in possession of 10.39% of company’s total shares while institution are holding 14.59 percent of that, with stock having share float percentage of 16.29%. Investors also watch the number of corporate investors in a company very closely, which is 14.59% institutions for PAVmed Inc that are currently holding shares of the company.